TriSalus Life Sciences In...

NASDAQ: TLSI · Real-Time Price · USD
4.61
0.73 (18.81%)
At close: Aug 15, 2025, 3:59 PM
4.60
-0.22%
After-hours: Aug 15, 2025, 07:51 PM EDT

TriSalus Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
26.49M 13M 8.53M 11.29M 16.48M 3.97M 11.78M 21.38M 3.9M 6.76M 9.41M 207.6K 69.18K 50.93K 200.88K 277.81K 642.94K 1.13M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 60.6M n/a n/a n/a n/a
Long-Term Investments
n/a 350K 350K 350K 350K 350K 350K 250K 12.08M 20.22M 19.83M 251.02M 250.29M 250.05M 250.01M 250.06M n/a n/a
Other Long-Term Assets
419K 74K 73K 74K 74K 424K 466K 367K 367K 367K 367K 4.34M n/a n/a 115K n/a 250.04M 250.04M
Receivables
5.57M 5.45M 5.09M 4.91M 4.71M 4.28M 3.55M 3.05M 2.09M 1.59M 1.56M 2.29M n/a n/a 1.36M n/a n/a n/a
Inventory
3.81M 4.16M 4.05M 4M 3.44M 2.91M 2.54M 1.63M 1.52M 1.72M 1.47M 1.29M n/a n/a 1.29M n/a n/a n/a
Other Current Assets
2.22M n/a n/a n/a n/a n/a n/a n/a 4.86M 4.96M n/a -3.58M n/a n/a -2.65M n/a n/a n/a
Total Current Assets
38.08M 25.1M 20.67M 23.81M 27.94M 13.19M 20.86M 29.04M 12.38M 15.19M 17.21M 306.22K 266.43K 346.81K 525.88K 702.37K 1.17M 1.76M
Property-Plant & Equipment
2.81M 3.1M 2.88M 3.25M 2.95M 3.16M 3.27M 3.15M 3.21M 3.43M 3.61M 3.35M n/a n/a 1.8M n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a 1.11M 1.11M 1.13M 997K 858K 847K 802K 737K n/a n/a 794K n/a n/a n/a
Total Long-Term Assets
3.23M 3.53M 3.3M 3.67M 4.49M 4.7M 4.86M 4.51M 4.43M 4.65M 4.78M 251.02M 250.29M 250.05M 250.01M 250.06M 250.04M 250.04M
Total Assets
41.32M 28.63M 23.97M 27.48M 32.43M 17.89M 25.73M 33.55M 16.81M 19.84M 22M 251.33M 250.55M 250.4M 250.53M 250.76M 251.21M 251.79M
Account Payables
n/a 2.81M 2.27M 1.45M 1.98M 2.35M 3.39M 1.9M 30.69K 4.46M 4.95M 2.36M 765.24K n/a 1.3M n/a n/a n/a
Deferred Revenue
n/a n/a n/a n/a n/a 11.42M n/a n/a 9.11M 6.18M 6.38M -944K -737.04K n/a n/a n/a n/a n/a
Short-Term Debt
123K n/a n/a 266K 323K 363K 351K 379K 384K n/a n/a 944K 944K 809K n/a n/a n/a n/a
Other Current Liabilities
9.2M 3.62M 383K 63K 6.44M -5.19M 38K 48K 22.67M 15.1M 23.89M -449.25K 765.24K 1.27M -242.38K 696.57K 354.01K 160.01K
Total Current Liabilities
9.32M 11.75M 10.23M 9.92M 12M 14.39M 14.69M 9.3M 32.19M 22.19M 32.36M 1.91M 1.74M 2.08M 1.06M 696.57K 354.01K 160.01K
Long-Term Debt
1.26M 31.7M 22.08M 21.68M 21.29M n/a n/a n/a 1.41M n/a n/a 700K 500K n/a 544K n/a n/a n/a
Other Long-Term Liabilities
50.15M 18.24M 16.22M 14.81M 22.14M 37.2M 35.73M 14.44M 181.57M 180.62M 164.38M 9.55M 9.81M 12.2M 15.65M 19.68M 22.33M 23.49M
Total Long-Term Liabilities
51.42M 51.24M 39.64M 37.99M 44.58M 38.42M 36.98M 15.76M 1.67M 182.12M 165.97M 10.25M 10.31M 12.2M 16.19M 19.68M 22.33M 23.49M
Total Liabilities
60.74M 62.99M 49.87M 47.91M 56.58M 52.81M 51.66M 25.07M 215.17M 204.31M 198.32M 12.16M 12.05M 14.28M 17.25M 20.37M 22.69M 23.65M
Total Debt
1.39M 33.12M 23.63M 23.45M 22.76M 1.58M 1.59M 1.7M 1.79M 1.87M 1.96M 1.64M 1.44M 809K 544K n/a n/a n/a
Common Stock
3K 3K 3K 3K 2K 2K 2K 2K 18K 18K 14K 250.83M 250.05M 250M 250M 250M 223.52M 223.14M
Retained Earnings
-298.21M -289.92M -279.55M -269.44M -265.93M -261.6M -248.38M -212.87M -211.58M -195.59M -186.36M -11.66M -11.54M -13.88M -16.72M -19.61M -704.56K -1.08M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a 1K -181.31M -180.36M -164.01M -0.00 n/a -129.6M -410.51M n/a n/a n/a
Shareholders Equity
-19.42M -34.37M -25.89M -20.43M -24.15M -34.92M -25.94M 8.49M -198.36M -184.47M -176.33M 239.17M 238.51M 236.12M 233.28M 230.39M 228.52M 228.14M
Total Investments
n/a 350K 350K 350K 350K 350K 350K 250K 12.08M 20.22M 19.83M 251.02M 250.29M 250.05M 250.01M 250.06M n/a n/a